Correlation Between Tekla Life and Morgan Stanley

Can any of the company-specific risk be diversified away by investing in both Tekla Life and Morgan Stanley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tekla Life and Morgan Stanley into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tekla Life Sciences and Morgan Stanley India, you can compare the effects of market volatilities on Tekla Life and Morgan Stanley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tekla Life with a short position of Morgan Stanley. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tekla Life and Morgan Stanley.

Diversification Opportunities for Tekla Life and Morgan Stanley

-0.25

Correlation Coefficient

Tekla Life  Morgan Stanley

Very good diversification

The 3 months correlation between Tekla and Morgan is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Tekla Life Sciences and Morgan Stanley India in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morgan Stanley India and Tekla Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tekla Life Sciences are associated (or correlated) with Morgan Stanley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morgan Stanley India has no effect on the direction of Tekla Life i.e., Tekla Life and Morgan Stanley go up and down completely randomly.

Pair Corralation between Tekla Life and Morgan Stanley

Considering the 90-day investment horizon Tekla Life Sciences is expected to generate 1.11 times more return on investment than Morgan Stanley. However, Tekla Life is 1.11 times more volatile than Morgan Stanley India. It trades about 0.0 of its potential returns per unit of risk. Morgan Stanley India is currently generating about -0.08 per unit of risk. If you would invest  1,306  in Tekla Life Sciences on December 27, 2024 and sell it today you would lose (5.00) from holding Tekla Life Sciences or give up 0.38% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Tekla Life Sciences  vs.  Morgan Stanley India

Tekla Life Sciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tekla Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Tekla Life is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Morgan Stanley India

Risk-Adjusted Performance

Very Weak

Over the last 90 days Morgan Stanley India has generated negative risk-adjusted returns adding no value to fund investors. Despite nearly stable forward indicators, Morgan Stanley is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Tekla Life and Morgan Stanley

The main advantage of trading using opposite Tekla Life and Morgan Stanley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tekla Life position performs unexpectedly, Morgan Stanley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morgan Stanley will offset losses from the drop in Morgan Stanley's long position.

The idea behind Tekla Life Sciences and Morgan Stanley India pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.